BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 27, 2007
View Archived Issues
Genentech, Abbott Partner To Develop Oncology Drugs
Genentech Inc. is acting the pharma part in a deal with Abbott to advance the latter's Phase I-stage compounds ABT-263 and ABT-869, a Bcl-2 protein antagonist and VEGF receptor kinase inhibitor, respectively. (BioWorld Today)
Read More
MediciNova Picks 2 Programs, Looks To Partner Most Others
Read More
Broader Comparison Finds More Specific Angiogenesis Markers
Read More
NewCo News: Cequent's RNAi Platform Draws Novartis Investment, Option
Read More
Generex Gears Up For Phase III Trial Of Oral-lyn Insulin Spray
Read More
Clinic Roundup
Read More
Other News To Note
Read More